| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |